Hsiang‐Cheng Chi

2.5k total citations
62 papers, 1.9k citations indexed

About

Hsiang‐Cheng Chi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hsiang‐Cheng Chi has authored 62 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 22 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Hsiang‐Cheng Chi's work include RNA modifications and cancer (14 papers), Cancer-related molecular mechanisms research (12 papers) and Cancer, Hypoxia, and Metabolism (8 papers). Hsiang‐Cheng Chi is often cited by papers focused on RNA modifications and cancer (14 papers), Cancer-related molecular mechanisms research (12 papers) and Cancer, Hypoxia, and Metabolism (8 papers). Hsiang‐Cheng Chi collaborates with scholars based in Taiwan, China and United States. Hsiang‐Cheng Chi's co-authors include Kwang‐Huei Lin, Chung‐Ying Tsai, Ming-Ming Tsai, Chau‐Ting Yeh, Yang-Hsiang Lin, Chia‐Siu Wang, Yi‐Hsin Tseng, I‐Hsiao Chung, Ya‐Hui Huang and Sheng‐Ming Wu and has published in prestigious journals such as PLoS ONE, Hepatology and Cancer Research.

In The Last Decade

Hsiang‐Cheng Chi

58 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hsiang‐Cheng Chi Taiwan 27 1.1k 818 263 228 219 62 1.9k
Elizabeth A. Williamson United States 33 3.0k 2.7× 999 1.2× 772 2.9× 198 0.9× 130 0.6× 71 3.8k
Hiroko Nagano Japan 20 585 0.5× 231 0.3× 278 1.1× 74 0.3× 81 0.4× 63 1.3k
Lucía Inglada‐Pérez Spain 22 681 0.6× 476 0.6× 385 1.5× 200 0.9× 83 0.4× 44 1.3k
Peter Ekman Sweden 33 1.6k 1.5× 726 0.9× 514 2.0× 418 1.8× 192 0.9× 115 3.9k
Luigi Moretti United States 28 746 0.7× 227 0.3× 400 1.5× 32 0.1× 524 2.4× 68 2.2k
Paul D. Crowe United States 29 887 0.8× 235 0.3× 376 1.4× 395 1.7× 173 0.8× 53 3.2k
Ge Wang China 20 729 0.7× 335 0.4× 250 1.0× 38 0.2× 113 0.5× 71 1.2k
Judith McKay United Kingdom 23 901 0.8× 599 0.7× 1.1k 4.4× 36 0.2× 177 0.8× 50 2.4k

Countries citing papers authored by Hsiang‐Cheng Chi

Since Specialization
Citations

This map shows the geographic impact of Hsiang‐Cheng Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsiang‐Cheng Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsiang‐Cheng Chi more than expected).

Fields of papers citing papers by Hsiang‐Cheng Chi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsiang‐Cheng Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsiang‐Cheng Chi. The network helps show where Hsiang‐Cheng Chi may publish in the future.

Co-authorship network of co-authors of Hsiang‐Cheng Chi

This figure shows the co-authorship network connecting the top 25 collaborators of Hsiang‐Cheng Chi. A scholar is included among the top collaborators of Hsiang‐Cheng Chi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsiang‐Cheng Chi. Hsiang‐Cheng Chi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chi, Hsiang‐Cheng. (2024). CCL16 is a pro-tumor chemokine that recruits monocytes and macrophages to promote hepatocellular carcinoma progression. American Journal of Cancer Research. 14(7). 3600–3613. 4 indexed citations
3.
Lin, Yang-Hsiang, Hsiang‐Cheng Chi, Chia‐Jung Liao, et al.. (2024). The novel role of LOC344887 in the enhancement of hepatocellular carcinoma progression via modulation of SHP1-regulated STAT3/HMGA2 signaling axis. International Journal of Biological Sciences. 20(15). 6281–6296. 2 indexed citations
4.
Tsai, Hung‐Wen, Yili Chen, Chun‐I Wang, et al.. (2023). Cisplatin or Doxorubicin Reduces Cell Viability via the PTPIVA3-JAK2-STAT3 Cascade in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 10. 123–138. 3 indexed citations
5.
Chi, Hsiang‐Cheng, et al.. (2023). YTHDF3 Modulates EGFR/ATK/ERK/p21 Signaling Axis to Promote Cancer Progression and Osimertinib Resistance of Glioblastoma Cells. Anticancer Research. 43(12). 5485–5498. 5 indexed citations
6.
Chen, Chih‐Jung, Yueh Chien, Wei-Chieh Huang, et al.. (2023). Calreticulin Expression Controls Cellular Redox, Stemness, and Radiosensitivity to Function as a Novel Adjuvant for Radiotherapy in Neuroblastoma. Oxidative Medicine and Cellular Longevity. 2023. 1–14. 1 indexed citations
7.
Liu, Yu‐Chin, Yang-Hsiang Lin, Hsiang‐Cheng Chi, et al.. (2022). CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance. Clinical Epigenetics. 14(1). 106–106. 13 indexed citations
8.
Tsai, Chung‐Ying, Hsiang‐Cheng Chi, Ren‐Chin Wu, et al.. (2021). Combination Biomarker of Immune Checkpoints Predict Prognosis of Urothelial Carcinoma. Biomedicines. 10(1). 8–8. 3 indexed citations
9.
Chi, Hsiang‐Cheng, Chung‐Ying Tsai, Ming-Ming Tsai, Chau‐Ting Yeh, & Kwang‐Huei Lin. (2019). Molecular functions and clinical impact of thyroid hormone-triggered autophagy in liver-related diseases. Journal of Biomedical Science. 26(1). 24–24. 73 indexed citations
10.
Lin, Yang-Hsiang, Meng‐Han Wu, Ya‐Hui Huang, et al.. (2018). Thyroid hormone negatively regulates tumorigenesis through suppression of BC200. Endocrine Related Cancer. 25(12). 967–979. 20 indexed citations
11.
Wu, Meng‐Han, Ya‐Hui Huang, Chau‐Ting Yeh, et al.. (2017). Taurine up‐regulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma. Hepatology. 67(1). 188–203. 127 indexed citations
12.
Tsai, Chung‐Ying, Chia‐Siu Wang, Ming-Ming Tsai, et al.. (2014). Interleukin-32 Increases Human Gastric Cancer Cell Invasion Associated with Tumor Progression and Metastasis. Clinical Cancer Research. 20(9). 2276–2288. 92 indexed citations
13.
Tsai, Ming-Ming, Chia‐Siu Wang, Chung‐Ying Tsai, et al.. (2014). MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer. Cancer Letters. 351(2). 222–231. 71 indexed citations
14.
Wu, Sheng‐Ming, Wanli Cheng, Chia‐Jung Liao, et al.. (2014). Negative modulation of the epigenetic regulator, UHRF1, by thyroid hormone receptors suppresses liver cancer cell growth. International Journal of Cancer. 137(1). 37–49. 24 indexed citations
15.
Huang, Ya-Hui, Hsiang‐Cheng Chi, Sheng‐Ming Wu, et al.. (2013). Thyroid Hormone Regulation of miR-21 Enhances Migration and Invasion of Hepatoma. Cancer Research. 73(8). 2505–2517. 50 indexed citations
16.
Chi, Hsiang‐Cheng, Ya‐Hui Huang, Chung‐Ying Tsai, et al.. (2013). Thyroid hormone receptor inhibits hepatoma cell migration through transcriptional activation of Dickkopf 4. Biochemical and Biophysical Research Communications. 439(1). 60–65. 24 indexed citations
17.
Tsai, Ming‐Ming, Paul Lin, Wanli Cheng, et al.. (2012). Overexpression of ADP‐ribosylation factor 1 in human gastric carcinoma and its clinicopathological significance. Cancer Science. 103(6). 1136–1144. 24 indexed citations
18.
Cheng, Wanli, Ming-Ming Tsai, Chung‐Ying Tsai, et al.. (2012). Correction: Glyoxalase-I Is a Novel Prognosis Factor Associated with Gastric Cancer Progression. PLoS ONE. 7(9). 18 indexed citations
19.
Chen, Cheng‐Yi, Lang‐Ming Chi, Hsiang‐Cheng Chi, et al.. (2011). Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC)-based Quantitative Proteomics Study of a Thyroid Hormone-regulated Secretome in Human Hepatoma Cells. Molecular & Cellular Proteomics. 11(4). M111.011270–M111.011270. 37 indexed citations
20.
Yeh, Chau‐Ting, Ya‐Hui Huang, Hsiang‐Cheng Chi, et al.. (2011). Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells. Hepatology. 55(3). 910–920. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth A. Williamson Breakdown of academic impact, for papers by Hiroko Nagano Breakdown of academic impact, for papers by Lucía Inglada‐Pérez Breakdown of academic impact, for papers by Peter Ekman Breakdown of academic impact, for papers by Luigi Moretti Breakdown of academic impact, for papers by Paul D. Crowe Breakdown of academic impact, for papers by Ge Wang Breakdown of academic impact, for papers by Judith McKay
Rankless by CCL
2026